OClawVPS.com
Edit

Alumni Ventures

https://www.av.vc/
Last activity: 17.11.2025
Active
Alumni Ventures offers diversified venture portfolios to accredited investors into highly competitive deals that individuals typically do not have access to on their own.
Portfolio
35
Persons
5
Mentions
118

Portfolio 35

DateNameWebsiteTotal RaisedLocation
11.11.2025Iambic The...iambic.ai$250MUnited Sta...
10.11.2025Hepta Biohepta.bio$6.7M-
29.10.2025Polygrafpolygraf.ai$9.5MUnited Sta...
29.10.2025CoreStorycorestory.ai$32MUnited Sta...
06.10.2025Heidi Heal...heidihealth.com$65MAustralia
18.09.2025Mobymoby.app$5MUnited Sta...
04.09.2025FriendliAIfriendli.ai$26.7MUnited Sta...
28.08.2025Alignmt AIalignmt.ai$6.5MUnited Sta...
07.08.2025Elionelion.ai$9.3MUnited Sta...
06.08.2025Elionelion.health$12.6MUnited Sta...
Show more

Persons 5

DateFirst NameLast NameTitleLinkedInLocation
-AntonSimunovic-linkedin.c...-
-DavidCareyInvestment...linkedin.c...-
-RachelBrown, MBATreasury M...linkedin.c...-
-RobertRausFund Accou...linkedin.c...-
-NancyFechnay-linkedin.c...-

Mentions in press and media 118

DateTitleDescription
17.11.2025Dubai Solidifies AI Supremacy: /function1 Returns in November 2025 as the Definitive Year-End Global AI NexusDubai, UAE – The new anchor of the global tech calendar: /function1 is returning to the Festival Arena, Dubai, on November 18–19, 2025. After an immensely successful first edition in May ’25, the conference is expanding to become the flagsh...
12.11.2025Hepta Unveils AI Liquid Biopsy for Chronic DiseaseHepta secures $6.7M. It pioneers AI-driven liquid biopsy for chronic diseases, starting with MASH. Its transformer AI platform analyzes cell-free DNA epigenomes. This delivers unparalleled precision in diagnosis. The non-invasive blood test...
12.11.2025AI-Driven Biotech Iambic Secures Over $100M for Drug DiscoveryIambic, a San Diego AI-driven biotech, secured over $100M in funding. This capital fuels its advanced AI drug discovery platform and expanding clinical pipeline. The company rapidly advances novel therapies, like IAM1363, showing strong ant...
11.11.2025Iambic Raises Over $100M in FundingIambic, a San Diego, CA-based clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, raised over $100M in funding. Backers included Abingworth, Alexandria Ventur...
10.11.2025Hepta Emerges from Stealth with $6.7M to Pioneer AI-Driven Chronic Disease Liquid BiopsyWhat You Should Know: – Hepta, a biotechnology company focused on diagnosing chronic disease, has emerged from stealth announcing $6.7M in seed funding co-led by Felicis Ventures and Illumina Ventures, with participation from SeaX Ventures,...
31.10.2025Polygraf AI Secures $9.5M Seed Funding for Enterprise AI SecurityPolygraf AI, an Austin-based leader in AI security, closed a $9.5 million seed funding round. Allegis Capital led the investment. The company's proprietary Small Language Models (SLMs) offer on-premise protection against deepfakes, fraud, a...
29.10.2025Polygraf AI Closes $9.5M Seed FundingPolygraf AI, an Austin, Texas-based provider of an AI security platform for critical operations, closed a $9.5M seed funding round. The round was led by Allegis Capital and participation from Alumni Ventures, DataPower VC, Domino Ventures a...
29.10.2025CoreStory: $32 Million Series A Closed For Legacy Software ModernizationCoreStory, a pioneer in AI-powered code intelligence, has raised $32 million in a Series A round led by Tribeca Venture Partners, NEA, and SineWave Ventures, with additional participation from Harrison Metal, Singtel Innov8, Samsung Next, N...
29.10.2025Polygraf AI: $9.5 Million Seed Funding Closed To Scale Enterprise AI Security SolutionsPolygraf AI, a Texas-based artificial intelligence security company, has raised $9.5 million in seed funding to accelerate its mission of securing enterprise and government AI ecosystems against threats such as deepfakes, data leaks, and AI...
07.10.2025AI Transforms Healthcare: Heidi Health Secures $65M for Global ExpansionHeidi Health, an Australian AI innovator, just closed a $65M Series B funding round, pushing its valuation to $465M. This significant investment fuels its global quest to revolutionize healthcare by equipping clinicians with an AI Care Part...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In